Diaa al-Awadi, despite losing his medical license, gained notoriety for his unconventional views on health treatments, including his rejection of insulin and chemotherapy.
Major funding is set to enhance research in diabetes and insomnia, alongside the establishment of a cutting-edge genome engineering facility in Australia.